Degendorfer P - Search Results

1

Maternal and foetal outcome following Hodgkin's disease in pregnancy.

Lishner M, Zemlickis D, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Lishner M, et al. Among authors: degendorfer p. Br J Cancer. 1992 Jan;65(1):114-7. doi: 10.1038/bjc.1992.21. Br J Cancer. 1992. PMID: 1733434 Free PMC article.

2

Fetal outcome after in utero exposure to cancer chemotherapy.

Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Zemlickis D, et al. Among authors: degendorfer p. Arch Intern Med. 1992 Mar;152(3):573-6. Arch Intern Med. 1992. PMID: 1546920

3

Maternal and fetal outcome after breast cancer in pregnancy.

Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Burke B, Sutcliffe SB, Koren G. Zemlickis D, et al. Among authors: degendorfer p. Am J Obstet Gynecol. 1992 Mar;166(3):781-7. doi: 10.1016/0002-9378(92)91334-7. Am J Obstet Gynecol. 1992. PMID: 1550143

4

Maternal and fetal outcome after invasive cervical cancer in pregnancy.

Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Zemlickis D, et al. Among authors: degendorfer p. J Clin Oncol. 1991 Nov;9(11):1956-61. doi: 10.1200/JCO.1991.9.11.1956. J Clin Oncol. 1991. PMID: 1941053

5

Second malignant neoplasms in patients with non Hodgkin's lymphoma.

Lishner M, Slingerland J, Barr J, Panzarella T, Degendorfer P, Sutcliffe S. Lishner M, et al. Among authors: degendorfer p. Hematol Oncol. 1991 May-Jun;9(3):169-79. doi: 10.1002/hon.2900090308. Hematol Oncol. 1991. PMID: 1937408

6

A Phase II trial of docetaxel and cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma.

McCarthy JS, Tannock IF, Degendorfer P, Panzarella T, Furlan M, Siu LL. McCarthy JS, et al. Among authors: degendorfer p. Oral Oncol. 2002 Oct;38(7):686-90. doi: 10.1016/s1368-8375(01)00134-8. Oral Oncol. 2002. PMID: 12167421 Clinical Trial.

7

A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancer.

Mackay H, Hedley D, Major P, Townsley C, Mackenzie M, Vincent M, Degendorfer P, Tsao MS, Nicklee T, Birle D, Wright J, Siu L, Moore M, Oza A. Mackay H, et al. Among authors: degendorfer p. Clin Cancer Res. 2005 Aug 1;11(15):5526-33. doi: 10.1158/1078-0432.CCR-05-0081. Clin Cancer Res. 2005. PMID: 16061869 Clinical Trial.

8

Optimizing clinical research procedures in public health emergencies.

Madariaga A, Kasherman L, Karakasis K, Degendorfer P, Heesters AM, Xu W, Husain S, Oza AM. Madariaga A, et al. Among authors: degendorfer p. Med Res Rev. 2021 Mar;41(2):725-738. doi: 10.1002/med.21749. Epub 2020 Nov 11. Med Res Rev. 2021. PMID: 33174617 Review.

9

A phase II study of PS-341 (Bortezomib) in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital and University of Chicago phase II consortia.

Gomez-Abuin G, Winquist E, Stadler WM, Pond G, Degendorfer P, Wright J, Moore MJ. Gomez-Abuin G, et al. Among authors: degendorfer p. Invest New Drugs. 2007 Apr;25(2):181-5. doi: 10.1007/s10637-006-9009-4. Epub 2006 Sep 16. Invest New Drugs. 2007. PMID: 16983508 Clinical Trial.

10

Evaluation of adverse events experienced by older patients participating in studies of molecularly targeted agents alone or in combination.

Townsley CA, Pond GR, Oza AM, Hirte HW, Winquist E, Goss G, Degendorfer P, Moore MJ, Siu LL. Townsley CA, et al. Among authors: degendorfer p. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2141-9. doi: 10.1158/1078-0432.CCR-05-1798. Clin Cancer Res. 2006. PMID: 16609027

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters